Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of ...

Pfizer-BioNTech inoculation may have broader effects on the immune system, helping to reduce inflammation in a way similar to ...

Researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended, primary target. They ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

New findings suggest the vaccine may reduce the production of pro-inflammatory mediators to bacterial, fungal or viral ...

Creative Diagnostics has announced its highly validated antibodies for tRNA Modification Detection. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Creative Diagnostics, a leading ...

For example, during SARS-CoV-2 infection, both T and B lymphocytes play critical roles in viral clearance and the generation ...

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...

Urgent Concerns Emerge Over mRNA Vaccine Safety Amidst Alarming Scientific Findings** In a revelation stirring controversy and raising urgent health concerns, independent resear ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines ...

The New York-based public benefit corporation is advancing three drug candidates for the extremely rare condition.

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...